Skip to main content
Skip to main navigation
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical Sales & Marketing
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Small to Mid-Sized Biopharma
Specialty Clinical Associations and Patient Organizations
Central Nervous System
Diabetes & Endocrinology
Early Phase Oncology
Public Health Interest
Other Therapeutic Areas
Ethics & Compliance
Fresh thinking grounded in reality across the full lifecycle
Tackle the new realities of drug development and commercialization with Quintiles’ broad industry expertise. The result: Strategies that drive success.
Getting UK Market Access Right:
The Importance of a Local Value Story in the New NHS
Read white paper
Quintiles’ survey examines engagement, alignment and transparency across the biopharma ecosystem.
Strategic Portfolio Management
How can good portfolio planning help to ensure commercial success of a product?
Read white paper
With access to all Quintiles’ experts, our integrated consulting teams bring you implementatble, sustainable solutions across the lifecycle.
A seismic power shift from providers to payers makes proving value an ongoing challenge.
Heightened regulatory scrutiny can turn compliance into a competitive edge.
Find out how
As market pressures mount, process efficiencies can make the difference between success and failure.
Quintiles Recognized as Industry Leader in Phase II/III Research for Second Year in a Row
Quintiles’ First Quarter 2014 Earnings Call Scheduled for Thursday, May 1st
Quintiles Appoints Dr. Stella Blackburn to Lead Global Risk Management
The Collaboration Mandate
Partnerships, Patients and Proof
Biomarkers: Recent Advances in their Application to the Treatment of Hematologic Malignancies